Breaks Categories: Stock Spotlights

TuesdayNov 17, 2020 3:46 pm

NetworkNewsBreaks – Rritual Superfoods Inc. Delivers ‘Daily Dose’ Through Flagship Product Line

Rritual, a plant-based consumer brand, is a natural wellness innovator positioned at the heart of a fledgling industry rife with opportunity. According to Grand View Research Inc., the overall functional foods market is projected to reach $275.77 billion by 2025 (https://nnw.fm/NO6n2), and the demand for nutraceuticals and functional foods is now expected to surge even more than anticipated. Rritual has entered the market with its flagship product line of certified organic mushroom and adaptogen elixir mix powders. The company’s non-psychoactive wellness elixirs include a Chaga blend designed to boost immunity, a Lion’s Mane blend designed to support cognitive function and…

Continue Reading

FridayNov 13, 2020 2:03 pm

NetworkNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Positioned at the Forefront of Reduced EV Manufacturing Costs

Net Element (NASDAQ: NETE) is transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. Timing looks optimal for the transition as new research from investment bank UBS finds that the cost to manufacture EVs may be the same as the cost for regular models within the next four years (https://nnw.fm/gPsnf). This news bodes well for Net Element and Mullen. A recent article discussing this reads, “Mullen recently announced its own plans to start work on a manufacturing facility as well as accept pre-orders for its M05 fully electric SUV.…

Continue Reading

ThursdayNov 12, 2020 3:32 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Poised at Convergence of AI, Cancer Care

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company, focuses on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. The company is set to play a key role as the integration of AI technology within cancer care continues to improve the accuracy and speed of diagnosis, aid in clinical decision-making and lead to better health outcomes. A recent article discussing growing opportunity in this sector reads, “The National Cancer Institute (‘NCI’) in the United States has separately revealed that it is increasingly looking to invest in supporting research and developing infrastructure centered around the usage of…

Continue Reading

ThursdayNov 12, 2020 3:10 pm

NetworkNewsBreaks – Why ev Transportation Services Inc. Is ‘One to Watch’

ev Transportation Services (“evTS”) is a designer, developer and manufacturer of all-electric lightweight commercial vehicles and fleet management solutions. The company is focused on the essential transportation services market. End-user applications for evTS vehicles include security, parking enforcement, local small package delivery, meter reading, sanitation, parks and recreation, university and corporate campuses, and warehouse operations services. A recent article discussing evTS reads, “The company’s flagship product is the FireFly ESV(R), a high-performance, low-maintenance electric vehicle with zero emissions. This utility vehicle was created specifically to meet the needs of essential services users. The FireFly ESV utilizes the safest Lithium Ion…

Continue Reading

WednesdayNov 11, 2020 2:37 pm

NetworkNewsBreaks – Why Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Is ‘One to Watch’

Josemaria Resources (TSX: JOSE) (OTC: JOSMF), a natural resources company based in Vancouver, British Columbia, is currently focused on advancing the development of its wholly owned Josemaria copper-gold mining project. The flagship project is located in the San Juan Province of Argentina – a well-known mining hub supporting a wide variety of mining service companies. The company, in its commitment to advance the project, has already begun the bridging phase and expects to commence basic and detailed engineering planning in early 2021. A recent article discussing Josemaria Resources reads, “The company recently announced the results of a feasibility study at…

Continue Reading

WednesdayNov 11, 2020 12:32 pm

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Leveraging Patented Science to Create Unique Products

Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, has turned its attention to a new space through acquisition of a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. The company’s newly created and wholly owned subsidiary — Kaival Labs — will own the patent and develop associated products. “The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel.…

Continue Reading

MondayNov 09, 2020 2:58 pm

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Eyes Opportunity Amid Growing Consumer Trend

Sharing Services Global (OTCQB: SHRG), a diversified holding company, is poised for growth as consumers crave wellness and prioritize healthy meals, good sleep and time to relax. A recent Ogilvy study reveals this growing consumer demand and identifies wellness as an essential element of a brand’s strategy (https://nnw.fm/zwzVu). While some brands are slow to respond, SHRG is distinct in its focus to capture opportunity amid this growing trend. An article discussing this reads, “Sharing Services Global is ideally positioned to capitalize on this gaping market opportunity as a company offering high-quality health and wellness products. In addition, as a direct-selling…

Continue Reading

MondayNov 02, 2020 2:44 pm

NetworkNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm

Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://nnw.fm/wPyaa). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than three decades of experience in the health-care sector and will continue to grow the company’s IP portfolio. “With his myriad of business accomplishments, Doug is the ideal leader for Cybin,” stated Cybin co-founder and COO Paul Glavine of the appointment. “We believe that his extensive health-care sector background and international company management skills will help Cybin strengthen partnerships, develop strategic alliances and expand our international…

Continue Reading

MondayNov 02, 2020 2:11 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Prioritizes Quality Through ‘The Future of Genetics’ Approach

Pac Roots (CSE: PACR), an innovative genetics-based cannabis company located in Canada, places a top priority on producing premium-quality cannabis strains and products. In fact, while competitors may strive to be the largest cannabis grower, Pac Roots, with its slogan proclaiming “the Future of Genetics,” maintains that the quality of the product is paramount. A recent article discussing this reads, “Pac Roots achieves its goal of producing the highest-quality cannabis by relying on superior genetics, following optimized farming systems and growing in carefully selected cultivation sites. The company’s commitment to superior genetics is represented by its strategic licensing agreement with…

Continue Reading

MondayNov 02, 2020 1:50 pm

NetworkNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company reads, “Headquartered in Hanover, Maryland, Processa has built a pipeline of drugs, which already have proof-of-concept data supporting clinical use in their selected indications. The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete. More specifically, Processa: acquires drugs that already have some clinical data to support the targeted treatment; navigates through…

Continue Reading